D57.218
Sickle-cell/Hb-C disease with crisis with other specified complication
Clinical Classification Guidelines
Use Additional Code
- code to identify complications, such as:
- cholelithiasis (K80.-)
- priapism (N48.32)
Medical Intelligence & Overview
Sickle-cell/Hb-C disease with crisis and other specified complications, coded as D57.218 in the ICD-10 classification, is a genetic blood disorder characterized by abnormal hemoglobin leading to distorted (sickled) red blood cells. These misshapen cells can block blood flow and cause various health issues. When crises occur, they can result in severe pain and potentially serious complications, impacting multiple organ systems. This guide aims to provide a clear understanding of this complex condition, its causes, symptoms, diagnosis, and management options.
Causes & Symptoms
Clinical Causes: Inherited genetic mutation affecting hemoglobin production Presence of the sickle hemoglobin (HbS) gene, often inherited from one or both parents Co-inheritance of Hemoglobin C gene (HbC), leading to combined sickle cell/Hb-C disease Genetic predisposition resulting in abnormal hemoglobin structure that causes red blood cells to sickle under stress or low oxygen conditions
Key Symptoms: Episodes of severe pain, called sickle cell crises Fatigue and weakness Swelling in the hands and feet Frequent infections Jaundice or yellowing of the skin and eyes Delayed growth and puberty in children Vision problems due to blockages in small blood vessels of the eyes Shortness of breath
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to assess red blood cell health and count Hemoglobin electrophoresis to identify abnormal hemoglobin variants (HbS and HbC) Blood smear microscopy to observe cell shape abnormalities Genetic testing to confirm specific mutations Imaging and organ-specific tests if complications are suspected
Treatment Protocols: Pain management during crises with medications such as analgesics and hydration Preventive antibiotics and vaccinations to reduce infection risk Blood transfusions to decrease the percentage of sickled cells and prevent stroke Medications like hydroxyurea that reduce the frequency of crises and protect organ function Folate supplements to support red blood cell production Monitoring and managing organ-specific complications, such as eye exams for visual issues and screenings for organ damage Bone marrow transplants may be considered in some cases for a potential cure
Clinical Advice & FAQs
Billing Guidance
Is D57.218 a billable ICD-10 code?
Yes, D57.218 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.218?
Clinical documentation must specify the nature of Sickle-cell/Hb-C disease with crisis with other specified complication and any associated comorbidities for accurate reporting.
Cite this Clinical Reference